Zurich Cantonal Bank’s NeoGenomics NEO Stock Holding History

Zurich Cantonal Bank’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,410	Closed	-$534K	–	3161
2025 Q4	$534K	Buy	+45,410	New	+$490K	﹤0.01%	1746

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Zurich Cantonal Bank's NEO Position: Q2 2026 in Review

Zurich Cantonal Bank held its NeoGenomics (NEO) position steady in Q2 2026 at 71,242 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Zurich Cantonal Bank first reported a position in NEO in Q2 2016 and has held it in 40 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Zurich Cantonal Bank held 71,242 shares of NeoGenomics worth $1.04M as of Q2 2026.
Zurich Cantonal Bank left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1530 holding.
Zurich Cantonal Bank first reported a position in NeoGenomics in Q2 2016 and has held it in 40 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.